Global Liraglutide Injection Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: April 28, 2021 |

The global liraglutide injection market size is accounted to register a significant CAGR of 13.7% over the forecast period and expected to reach USD 14 billion by 2027. The rising prevalence of type 2 diabetes worldwide primarily drives the liraglutide injection market growth. Additionally, the growing incidence of obesity among the young populations across the globe further accentuates the market growth.

Liraglutide is basically a synthetic analog of human glucagon-like peptide-1(GLP-1) and is considered as a GLP-1 receptor agonist, it is 97% homologous to the native GLP-1 by substituting the arginine in the place of lysine at the position of 34. In January 2010 it received approval from the FDA for the management of type 2 diabetes and is currently the sole property of Novo Nordisk A/S.

Market Segment Insights:

Type 2 diabetes is representing the largest market share in the clinical application for the liraglutide injection market. According to the latest statistics provided by the International Diabetes Federation (IDF), it is estimated that in 2019 approximately 463 million adult population are suffering from type 2 diabetes. The disease progression is a combination of both genetic and lifestyle disorders. The pathophysiology of type 2 diabetes is attributed to 3 clinical factors which are decreased insulin secretion, elevated hepatic glucose production, and increased insulin resistance, etc. Obesity is keen to register impressive market growth during the forecast period on account of the increasing consumption of junk food, alcohol, tobacco, and sedentary lifestyle among the young adult population worldwide. As per the latest information provided by the World Health Organization (WHO), approximately 13% of the global population is anticipated to be suffering from obesity, further clinical investigation states the prevalence rate of 11% and 15% in the men and women population respectively.

Liraglutide Injection Market Size & Growth

To know more about the study, request a report sample

Hospital pharmacy is currently leading the distribution channel segment in the liraglutide injection market. High risk of disease progression of pancreatitis with the injudicious use of liraglutide injection, makes it imperative for precise dispensing of medicine under the supervision of a hospital pharmacist. It is expected that in the near future retail pharmacy will be showcasing exemplary market growth in the developing regions of the world owing to the provision of cheap medicines due to the imposition of government subsidy for essential medicines.

The liraglutide injection comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market, and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The liraglutide injection market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Liraglutide Injection Market Segmentation:

By Clinical Application:

  • Type 2 Diabetes
  • Obesity

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

North America is presently dominating the geography segment for the liraglutide injection market. The rising prevalence of type 2 diabetes primarily drives the liraglutide market growth in the region. As per the latest research citings presented by the American Diabetes Association (ADA), approximately 9% of the population in the U.S. is suffering with type 2 diabetes. Additionally, the supportive regulatory environment provided by the USFDA in the sale and marketing of liraglutide injection further propel the market growth in the region. Europe is considered as the second-largest regional segment in the liraglutide injection market. The rising prevalence of obesity in the young population determines the liraglutide injection market growth in the region. Asia Pacific is anticipated to be the fastest-growing regional segment in the liraglutide market on account of the developing healthcare infrastructure and rising public health awareness regarding the therapeutic efficacy of liraglutide in the management of type 2 diabetes and obesity prevalence in the Asia Pacific region.

Market Competition Assessment:

Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy. Key players operating in the global liraglutide injection market are Novo Nordisk A/S.

Key Questions Answered by Liraglutide Injection Market Report:

  • Global liraglutide injection market forecasts from 2021-2027
  • Regional liraglutide injection market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Liraglutide injection submarket forecasts from 2021-2027 covering the market by clinical application, by distribution channel, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to liraglutide injection market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level liraglutide injection markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the liraglutide injection market
Table of Content:

Chapter 1. Introduction


1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Scope
1.3.1. Market Segmentation
1.3.2. Years Considered for the Study
1.4. Currency
1.5. Limitation
1.6. Market Stakeholders

 

Chapter 2. Research Methodology


2.1. Market Size Estimation
2.2. Market Breakdown and Data Triangulation
2.3. Market Share Estimation
2.4. Key Data From Secondary Sources
2.5. Key Data From Primary Sources
2.6. Key Industry Insights
2.7. Assumptions for the Study

 

Chapter 3. Executive Summary


3.1. Global Liraglutide Injection Market Snapshot
3.2. Global Liraglutide Injection Market, by Clinical Application, 2020 (US$ Mn)
3.3. Global Liraglutide Injection Market, By Distribution Channel, 2020 (US$ Mn)
3.4. Global Liraglutide Injection Market, by Geography, 2020 (US$ Mn)

 

Chapter 4. Liraglutide Injection Market: Dynamics and Future Outlook


4.1. Market Overview
4.2. Drivers
4.3. Challenges
4.4. Opportunities
4.5. Attractive Investment Proposition, by Geography, 2020

 

Chapter 5. Global Liraglutide Injection Market, By Clinical Application


5.1. Introduction
5.2. Type 2 Diabetes
5.3. Obesity

 

Chapter 6. Global Liraglutide Injection Market, By Distribution Channel


6.1. Introduction
6.2. Hospital Pharmacy
6.3. Retail Pharmacy
6.4. Others

 

Chapter 7. Global Liraglutide Injection Market, by Geography


7.1. Introduction
7.1. North America Liraglutide Injection Market Analysis, 2017 – 2027
7.1.1. North America Liraglutide Injection Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.1.2. North America Liraglutide Injection Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.1.3. North America Liraglutide Injection Market, by Country, 2017 – 2027 (US$ Mn)
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe Liraglutide Injection Market Analysis, 2017 – 2027
7.2.1. Europe Liraglutide Injection Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.2.2. Europe Liraglutide Injection Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.2.3. Europe Liraglutide Injection Market, by Country, 2017 – 2027 (US$ Mn)
7.2.3.1. U.K.
7.2.3.2. Germany
7.2.3.3. Russia
7.2.3.4. France
7.2.3.5. Italy
7.2.3.6. Spain
7.2.3.7. Ukraine
7.2.3.8. Rest of Europe
7.3. Asia Pacific Liraglutide Injection Market Analysis, 2017 – 2027
7.3.1. Asia Pacific Liraglutide Injection Market, By Clinical Application, 2017 – 2027 (US$ Mn)
7.3.2. Asia Pacific Liraglutide Injection Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.3.3. Asia Pacific Liraglutide Injection Market, by Country, 2017 – 2027 (US$ Mn)
7.3.3.1. China
7.3.3.2. Japan
7.3.3.3. Rest of Asia Pacific
7.4. Latin America Liraglutide Injection Market Analysis, 2017 – 2027
7.4.1. Latin America Liraglutide Injection Market, By Clinical Application, 2017 – 2027 (US$ Mn)
7.4.2. Latin America Liraglutide Injection Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.4.3. Latin America Liraglutide Injection Market, by Country, 2017 – 2027 (US$ Mn)
7.4.3.1. Brazil
7.4.3.2. Mexico
7.4.3.3. Rest of Latin America
7.5. Middle East and Africa Liraglutide Injection Market Analysis, 2017 – 2027
7.5.1. MEA Liraglutide Injection Market, by Clinical Application, 2017 – 2027 (US$ Mn)
7.5.2. MEA Liraglutide Injection Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
7.5.3. MEA Liraglutide Injection Market, by Country/Region, 2017 – 2027 (US$ Mn)
7.5.3.1. GCC
7.5.3.2. Rest of MEA

 

Chapter 8. Company Profiles


8.1. Novo Nordisk A/S
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Recent Developments
8.1.5. SWOT Analysis

To know more about the study, request a report sample

List of Figures:

FIG. 1 Liraglutide Injection: Market Segmentation
FIG. 2 Global Liraglutide Injection Market, by Clinical Application, 2019 (US$ Mn)
FIG. 3 Global Liraglutide Injection Market, By Distribution Channel, 2019 (US$ Mn)
FIG. 4 Global Liraglutide Injection Market, by Geography, 2019 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2019
FIG. 6 Global Type 2 Diabetes Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 7 Global Obesity Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 8 Global Hospital Pharmacy Market for Liraglutide Injection, 2017 – 2027 (US$ Mn)
FIG. 9 Global Retail Pharmacy Market for Liraglutide Injection, 2017 – 2027 (US$ Mn)
FIG. 10 Global Other Distribution Channel Market for Liraglutide Injection, 2017 – 2027 (US$ Mn)
FIG. 11 U.S. Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 12 Canada Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 13 U.K. Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 14 Germany Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 15 Russia Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 16 France Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 17 Italy Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 18 Spain Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 19 Ukraine Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 20 Rest of Europe Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 21 China Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 22 Japan Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 23 Rest of Asia Pacific Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 24 Brazil Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 25 Mexico Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 26 Rest of Latin America Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 27 GCC Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 28 Rest of MEA Liraglutide Injection Market, 2017 – 2027 (US$ Mn)
FIG. 29 Liraglutide Injection Market: Research Methodology

To know more about the study, request a report sample

List of Tables:

TABLE 1 Global Liraglutide Injection Market Snapshot
TABLE 2 Global Liraglutide Injection Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 3 Global Liraglutide Injection Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 4 Global Liraglutide Injection Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 5 North America Liraglutide Injection Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 6 North America Liraglutide Injection Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 7 North America Liraglutide Injection Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe Liraglutide Injection Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 9 Europe Liraglutide Injection Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 10 Europe Liraglutide Injection Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific Liraglutide Injection Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific Liraglutide Injection Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 13 Asia Pacific Liraglutide Injection Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 14 Latin America Liraglutide Injection Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America Liraglutide Injection Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America Liraglutide Injection Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa Liraglutide Injection Market, by Clinical Application, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa Liraglutide Injection Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa Liraglutide Injection Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 Novo Nordisk A/S.: Company Snapshot (Business Description; Financial Information; Product Portfolio; SWOT Analysis; Recent Developments)
Fill the given form to inquiry before buying for Liraglutide Injection Market Report

Your Designtaion (required):


(Additional country analysis and conmapny analysis will be added according to request, please read our FAQs below:)(Reports covers the COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying



Frequently Asked Questions (FAQs):
A. Yes, we provide customization with every report to fulfill your market research requirement.
A. No, generally we don’t charge for report customization.
A. Yes, we will add the more coutries analysis in the report, please mention the countries you are looking.
A. Yes, we provide research support for all our clients to resolve their issue regarding the report.
A. Yes, you can purchase only a regional or a country market report with our best price which is less than the global report.
A. Yes, we provide a better discount for startups and individuals.
A. Our database consists of over 70,000 market research reports; if still not available on the website, feel free to write us. Our team will be happy to assist you in the same. Let us know if you are looking for the dataset.
(For more information, feel free to write us at sales@researchcorridor.com)
Select License Type
$3200/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client are returning clients
  • 100,000+ data points in our comprehensive database
  • 24x5 availability - we are always there when you need us
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report

Impacts of COVID-19
COVID-19 Impact on the Liraglutide Injection Market

For Any Assitance

Call Us: +1 520-686-7060
Email: sales@researchcorridor.com

Our Clients